Centenial Surgical Suture standalone net profit declines 50.00% in the June 2021 quarter

Centenial Surgical Suture reports standalone net loss of Rs 0.04 crore in the March 2021 quarter

Centenial Surgical Suture standalone net profit declines 2.33% in the December 2020 quarter

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Centenial Surgical Suture is a medical device company engaged in manufacturing surgical sutures and other medical devices. It's products include atraumatic needles and sutures (absorbable and non absorbable) and cardio blades

Centenial Surgical Suture Ltd

Centenial Surgical Suture Ltd

Scorecard

News & Opinions

Centenial Surgical Suture standalone net profit declines 50.00% in the June 2021 quarter

Centenial Surgical Suture reports standalone net loss of Rs 0.04 crore in the March 2021 quarter

Centenial Surgical Suture standalone net profit declines 2.33% in the December 2020 quarter